{"article_title": "Biologic Drug Competition Means Lower Consumer Prices", "article_keywords": ["lower", "means", "drug", "biologic", "competition", "prices", "consumer"], "article_url": "http://www.forbes.com/sites/stevepociask/2015/11/19/biologic-drug-competition-means-lower-consumer-prices/", "article_text": "", "article_metadata": {"description": "Photographer: Aaron Harris/Bloomberg When it comes to drug prices, what\u2019s dominating the headlines is bad news story after bad news story. Turing Pharmaceuticals raised the price of an old AIDS drug by more than 5,000 percent overnight, and Valeant Pharmaceuticals International raised a blood pressure drug price by nearly 3,000 percent [...]", "author": "Steve Pociask", "og": {"site_name": "Forbes", "description": "Photographer: Aaron Harris/Bloomberg When it comes to drug prices, what\u2019s dominating the headlines is bad news story after bad news story. Turing Pharmaceuticals raised the price of an old AIDS drug by more than 5,000 percent overnight, and Valeant Pharmaceuticals International raised a blood pressure drug price by nearly 3,000 percent [...]", "title": "Biologic Drug Competition Means Lower Consumer Prices", "url": "http://www.forbes.com/sites/stevepociask/2015/11/19/biologic-drug-competition-means-lower-consumer-prices/", "image": "http://specials-images.forbesimg.com/imageserve/34049553/640x434.jpg?fit=scale", "updated_time": "2015-11-19T12:06:19-05:00", "type": "article"}, "twitter": {"description": "Photographer: Aaron Harris/Bloomberg When it comes to drug prices, what\u2019s dominating the headlines is bad news story after bad news story. Turing Pharmaceuticals raised the price of an old AIDS drug by more than 5,000 percent overnight, and Valeant Pharmaceuticals International raised a blood pressure drug price by nearly 3,000 percent [...]", "creator": "@ConsumerPal", "image": "http://specials-images.forbesimg.com/imageserve/34049553/640x434.jpg?fit=scale", "title": "Biologic Drug Competition Means Lower Consumer Prices", "site": "@forbes", "card": "summary_large_image"}, "apple-itunes-app": "app-id=588647136", "fb": {"app_id": 123694841080850}, "keywords": "OpEd,Science  Technology,Op/Ed,Science &amp; Technology", "article": {"publisher": "https://www.facebook.com/forbes", "section_url": "http://www.forbes.com/opinion", "section": "Opinion", "modified": "2015-11-19", "published": "2015-11-19", "id": "blogAndPostId/blog/post/3966-83"}, "news_keywords": "OpEd,Science  Technology,Op/Ed,Science &amp; Technology", "viewport": "width=device-width,initial-scale=1,maximum-scale=1,user-scalable=no", "prerender-status-code": "{{meta.code}}"}, "article_summary": ""}